Highlights

  • MVE seeks to track the S&P/ASX MidCap 50 Index, providing exposure to companies outside the S&P/ASX 50.
  • Basic materials represented 25.18%, followed by healthcare at 14.38% of sector exposure.
  • The portfolio listing contained 51 holdings, with its ten largest positions representing 29.53%.
  • Management fees and costs were listed at 0.45%, with fund size of AUD 518.98 million.

VanEck S&P/ASX MidCap ETF (ASX:MVE) provides exposure to a segment of Australian-listed companies outside the S&P/ASX 50 through the S&P/ASX MidCap 50 Index. The fund seeks to track its benchmark rather than select companies independently through an active mandate. At the time of writing on 6 November 2026, MVE was trading at AUD 45.14. Its holdings span materials, healthcare, financial services, property and technology, with relatively modest individual weights among the leading positions.

Midcap exposure is defined relative to the market

The benchmark covers 50 companies across industry sectors and gives the fund a company universe distinct from a portfolio dominated by the largest ASX issuers. Midcap is a relative market segment: it does not mean that the constituent businesses must have very low absolute market values.

Companies above AUD 1 billion represented 99.00% of the reported Market Capitalisation breakdown. The portfolio listing contained 51 holdings, a reported count that should be distinguished from the benchmark’s 50-company mandate. The asset allocation was entirely equities, making this an Australian share exposure rather than a diversified allocation across asset classes.

Materials healthcare and leading company positions

Basic materials accounted for 25.18% of sector exposure, healthcare 14.38%, financial services 10.44%, real estate 9.79% and technology 9.56%. Energy represented 7.90%, industrials 7.42%, consumer cyclical companies 5.91% and consumer defensive companies 4.15%.

Orica was the largest holding at 3.35%, followed by Ramsay Health Care at 3.25%, Ampol at 3.24% and Sandfire Resources at 3.15%. Vicinity Centres, Cochlear, Pro Medicus, Charter Hall, Perseus Mining and Genesis Minerals completed the top ten. These positions represented 29.53%, leaving most of the allocation outside the leading ten holdings and spreading company exposure more widely across the portfolio.

Geography costs and distribution details

Geographic exposure was 89.89% Australia, 4.28% United Kingdom, 2.22% United States, 2.12% New Zealand and 1.49% China. These classifications describe the holdings and do not measure the location of every operating asset or Revenue source within the companies.

Management fees and costs were listed at 0.45%. A final distribution of AUD 0.630 per unit had an ex-distribution date of 1 July 2026, a Record Date of 2 July and payment on 27 July. Future payments can vary. Midcap market exposure, changes in index membership and sector conditions remain relevant risks even where individual company weights are relatively small.

Key Insights

MVE accesses a defined Australian midcap segment beyond the largest 50 companies. Its leading holdings have relatively modest weights, while materials and healthcare remain significant sector exposures. The benchmark’s relative size definition is important when interpreting the portfolio’s predominantly billion-dollar company profile.